CHEST Updates Guideline for Managing Neuromuscular Weakness
The guideline contains 15 evidence-based recommendations, a good practice statement, and an ungraded consensus-based statement.
The guideline contains 15 evidence-based recommendations, a good practice statement, and an ungraded consensus-based statement.
Vitalograph is celebrating 21 years of empowering respiratory research through clinical trials services, with international team members fundraising for local respiratory charities to mark the milestone.
The global COPD burden could be significantly reduced in low and middle-income countries by assessing patients via questionnaire and peak expiratory flow device, according to an international study published in JAMA.
The US FDA has issued clearance for Cognita Labs’ PulmoScan, the first at-home lung assessment device that measures airway resistance and elastance.
Read MoreCOVID-19 infection does not appear to affect the lung function of young adults, children or adolescents, according to two research studies presented at ERS 2021.
Read MorePulmonary function tests contribute helpful diagnostic information for evaluating patients with vaping-related lung injury.
Read MoreA closer look as some of the latest spirometers and pulmonary function testing (PFT) diagnostic devices on the market from CosMed USA, FutureMed, Hans Rudolph, MGC Diagnostics, Micro Direct, Morgan Scientific, ndd Medical, Vacumed, and Vitalograph.
Read MoreMGC Diagnostics is giving away 20 signed copies of Ruppel’s Manual of Pulmonary Function Testing (11th edition), signed by authors Gregg Ruppel and Carl Mottram.
Read MoreA new cystic fibrosis treatment involves nucleic acid molecules called oligonucleotides that can correct gene defects related to CF.
Read MoreA report in JAMA Internal Medicine reveals the socioeconomic disparities in pulmonary disease, respiratory symptoms and lung function.
Read MoreA startup company developing a video game-based pulmonary rehab device adapted its product into a home spirometer during the COVID-19 pandemic with the support of NIH/NHLBI funding.
Read MoreThe removal of race correction in PFT results led to an increase in the percentage of patients with any pulmonary defect from 59.5% to 81.7%, a significant difference of 20.8%.
Read MoreVitalograph has released a new generation Pneumotrac spirometer in the United States, along with its upgraded Spirotrac 6 Software.
Read MoreA woman in Michigan contracted COVID-19 and died after receiving an infected double-lung transplant from a donor, according to multiple news reports.
Read MoreObjective tools that are useful in making a diagnosis and in management of asthma include spirometry and Fractional exhaled nitric oxide (FeNO). However, there are complications and challenges in obtaining patient data with the changes brought by the COVID-19 pandemic.
Read More